Abstract
Chronic rhinosinusitis is a prevalent condition known to impair the quality of life (QOL) of patients with the condition. There is a growing understanding of the direct and indirect cost burden to both the patients and the society. Loss of productivity, medication usage, and hospitalisation costs are significant. Sinus surgery is usually considered only when medical management fails. There is a paucity of randomised data; however, evidence supports the role of surgery in reducing the impact of CRS on QOL. Often performed in a day-case setting, the costs of surgery are relatively modest. Cost-effectiveness studies suggest that surgery becomes a cost-effective strategy compared with 2–3 years of ongoing medical management. There are insufficient data to currently define the optimum timing of a nature of surgery performed from a cost-effectiveness perspective.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Halawi AM, Smith SS, Chandra RK. Chronic rhinosinusitis: epidemiology and cost. Allergy Asthma Proc. 2013;34(4):328–34.
Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy. 2009;64(4):520–33.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;3:1–298.
Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol Head Neck Surg. 2011;144(3):440–5.
Bhattacharyya N. Clinical outcomes after endoscopic sinus surgery. Curr Opin Allergy Clin Immunol. 2006;6(3):167–71.
Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope. 2009;119(12):2459–65.
Bhattacharyya N. Symptom outcomes after endoscopic sinus surgery for chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2004;130(3):329–33.
Masterson L, Agalato E, Pearson C. Image-guided sinus surgery: practical and financial experiences from a UK centre 2001-2009. J Laryngol Otol. 2012;126(12):1224–30.
Ference EH, Graber M, Conley D, Chandra RK, Tan BK, Evans C, et al. Operative utilization of balloon versus traditional endoscopic sinus surgery. Laryngoscope. 2015;125(1):49–56.
Sahlstrand-Johnson P, Ohlsson B, Von Buchwald C, Jannert M, Ahlner-Elmqvist M. A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology. 2011;49(4):420–8.
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34(5):447–54.
Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol. 2011;120(7):423–7.
Bhattacharyya N. Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am J Rhinol Allergy. 2012;26(2):120–2.
Rudmik L, Smith TL, Schlosser RJ, Hwang PH, Mace JC, Soler ZM. Productivity costs in patients with refractory chronic rhinosinusitis. Laryngoscope. 2014;124(9):2007–12.
Murphy MP, Fishman P, Short SO, Sullivan SD, Yueh B, Weymuller EA Jr. Health care utilization and cost among adults with chronic rhinosinusitis enrolled in a health maintenance organization. Otolaryngol Head Neck Surg. 2002;127(5):367–76.
Chung SD, Hung SH, Lin HC, Lin CC. Health care service utilization among patients with chronic rhinosinusitis: a population-based study. Laryngoscope. 2014;124(6):1285–9.
•• Rudmik L, Soler ZM, Mace JC, Schlosser RJ, Smith TL. Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015;125(1):25–32. Major Importance using a Markhov decision-tree econmic evaluation, Rudmik et al demontratde that ESS is a more cost-effective strategy for long term management of CRS compared with medical treatment alone.
Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma. 2009;46(1):73–80.
Ward MM, Javitz HS, Smith WM, Bakst A. A comparison of three approaches for attributing hospitalizations to specific diseases in cost analyses. Int J Technol Assess Health Care. 2000;16(1):125–36.
Smith WM, Davidson TM, Murphy C. Regional variations in chronic rhinosinusitis, 2003-2006. Otolaryngol Head Neck Surg. 2009;141(3):347–52.
Bhattacharyya N. The economic burden and symptom manifestations of chronic rhinosinusitis. Am J Rhinol. 2003;17(1):27–32.
Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat. 1999;(200):1–203.
Au J, Rudmik L. Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time-driven activity-based costing approach. Int Forum Allergy Rhinol. 2013;3(9):748–54.
Gliklich RE, Metson R. Economic implications of chronic sinusitis. Otolaryngol Head Neck Surg. 1998;118(3 Pt 1):344–9.
• Benninger MS, Holy CE. Endoscopic sinus surgery provides effective relief as observed by health care use pre- and postoperatively. Otolaryngol Head Neck Surg. 2014;150(5):893–900. Importance—administrative claims database analysis demonstrates significant reduction is health-care utilisation post ESS, returning to baseline levels by 13 weeks after surgery.
Al Badaai Y, Valdes CJ, Samaha M. Outcomes and cost benefits of functional endoscopic sinus surgery in severely asthmatic patients with chronic rhinosinusitis. J Laryngol Otol. 2014;128(6):512–7.
Benninger MS, Holy CE. The impact of endoscopic sinus surgery on health care use in patients with respiratory comorbidities. Otolaryngol Head Neck Surg. 2014;151(3):508–15.
Rudmik L, Mace J, Soler ZM, Smith TL. Long-term utility outcomes in patients undergoing endoscopic sinus surgery. Laryngoscope. 2014;124(1):19–23.
Bhattacharyya N, Grebner J, Martinson NG. Recurrent acute rhinosinusitis: epidemiology and health care cost burden. Otolaryngol Head Neck Surg. 2012;146(2):307–12.
Poetker DM, Litvack JR, Mace JC, Smith TL. Recurrent acute rhinosinusitis: presentation and outcomes of sinus surgery. Am J Rhinol. 2008;22(3):329–33.
Bhandarkar ND, Mace JC, Smith TL. Endoscopic sinus surgery reduces antibiotic utilization in rhinosinusitis. Int Forum Allergy Rhinol. 2011;1(1):18–22.
Smith KA, Smith TL, Mace JC, Rudmik L. Endoscopic sinus surgery compared to continued medical therapy for patients with refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(10):823–7.
Smith TL, Kern RC, Palmer JN, Schlosser RJ, Chandra RK, Chiu AG, et al. Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study. Int Forum Allergy Rhinol. 2011;1(4):235–41.
Leung RM, Dinnie K, Smith TL. When do the risks of repeated courses of corticosteroids exceed the risks of surgery? Int Forum Allergy Rhinol. 2014;4(11):871–6.
Hopkins C, Lund V. Does time to endoscopic sinus surgery impact outcomes? Prospective findings from the national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Rhinology. 2015. [Epub ahead of print].
Hopkins C AP, Holy C. Does time to surgery impact on outcomes from endoscopic sinus surgery - data from the UK CPRD database. Rhinology. 2015. [Epub ahead of print].
Benninger M SP, Holy C, Hopkins C. Early versus delayed endoscopic sinus surgery in pateints with chronic rhinosinusitis: impact on healthcare utilization. Otolaryngol Head Neck Surg. 2014. doi:10.1177/0194599814565606.
Gibbons MD, Gunn CG, Niwas S, Sillers MJ. Cost analysis of computer-aided endoscopic sinus surgery. Am J Rhinol. 2001;15(2):71–5.
Dalgorf DM, Sacks R, Wormald PJ, Naidoo Y, Panizza B, Uren B, et al. Image-guided surgery influences perioperative morbidity from endoscopic sinus surgery: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013;149(1):17–29.
Bhattacharyya N. Progress in surgical management of chronic rhinosinusitis and nasal polyposis. Curr Allergy Asthma Rep. 2007;7(3):216–20.
Kumar N, Sindwani R. Bipolar microdebrider may reduce intraoperative blood loss and operating time during nasal polyp surgery. Ear Nose Throat J. 2012;91(8):336–44.
Cornet ME, Reinartz SM, Georgalas C, van Spronsen E, Fokkens WJ. The microdebrider, a step forward or an expensive gadget? Rhinology. 2012;50(2):191–8.
Friedman M, Schalch P, Lin HC, Mazloom N, Neidich M, Joseph NJ. Functional endoscopic dilatation of the sinuses: patient satisfaction, postoperative pain, and cost. Am J Rhinol. 2008;22(2):204–9.
Karanfilov B, Silvers S, Pasha R, Sikand A, Shikani A, Sillers M. Office-based balloon sinus dilation: a prospective, multicenter study of 203 patients. Int Forum Allergy Rhinol. 2013;3(5):404–11.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Rhinology.
Rights and permissions
About this article
Cite this article
Bernic, A., Dessouky, O., Philpott, C. et al. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis. Curr Otorhinolaryngol Rep 3, 117–123 (2015). https://doi.org/10.1007/s40136-015-0077-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40136-015-0077-x